Evidence map›Paper›PMID 11847099›Full record

ArticleThe EMBO journal2002

Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors.

S Costagliola, V Panneels, M Bonomi, J Koch, M C Many, G Smits, G Vassart

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 225 citations in OpenAlex.

  1. Review
  2. Searching for Sulfotyrosines (sY) in a HA(pY)STACK.Journal of proteome research · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

S CostagliolaI.R.I.B.H.N. and Department of Medical Genetics, ULB, 808 Lennik Street, B-1070 Brussels, Belgium. scostag@ulb.ac.be
V Panneels
M Bonomi
J Koch
M C Many
G Smits
G Vassart

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The glycoprotein hormone receptors (thyrotrophin receptor, TSHr; luteinizing hormone/chorionic gonadotrophin receptor, LH/CGr; follicle-stimulating hormone receptor, FSHr) constitute a subfamily of rhodopsin-like G protein-coupled receptors (GPCRs) with a long N-terminal extracellular extension responsible for high-affinity hormone binding. These ectodomains contain two cysteine clusters flanking nine leucine-rich repeats (LRR), a motif found in several protein families involved in protein-protein interactions. Similar to the situation described recently in CCR5, we demonstrate here that the TSHr, as it is present at the cell surface, is sulfated on tyrosines in a motif located downstream of the C-terminal cysteine cluster. Sulfation of one of the two tyrosines in the motif is mandatory for high-affinity binding of TSH and activation of the receptor. Site-directed mutagenesis experiments indicate that the motif, which is conserved in all members of the glycoprotein hormone receptor family, seems to play a similar role in the LH/CG and FSH receptors.

Indexed as

Amino Acid SequenceAnimalsAntibodies, MonoclonalAutoantibodiesEpitopesHumansImmunohistochemistryMolecular Sequence DataReceptors, Cell SurfaceSequence Homology, Amino AcidSulfuric AcidsTyrosineAntibodies, MonoclonalAutoantibodiesEpitopesReceptors, Cell SurfaceSulfuric AcidsTyrosine

Identifiers

PMID11847099
PMCPMC125869
OpenAlexW1986447682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.